# The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility

> **NCT05222841** · PHASE2,PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 150 (actual)

## Conditions studied

- Male Infertility
- Benign Prostatic Hyperplasia
- Spermatogenesis and Semen Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Spermotrend

## Key facts

- **NCT ID:** NCT05222841
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-15
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-12-15
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05222841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05222841, "The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05222841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
